glp-1 type 1 diabetes news Could Receptor Agonists Help Prevent Infections in People with Diabetes? A Nationwide Study Says Yes—At Least for the Lungs and Feet #ActAgainstAmputation #DiabeticFoot #GLP1RA Targeting GLP-1, GIP & GCG

There are several practical reasons why an individual might find a personalized program more beneficial

I dont have any patients on a compounded GLP-1, but if I did, and they were taking a pretty high dose, there would be many factors we would discuss

The most common are gastrointestinal: nausea (experienced by 20-40% of patients, usually diminishing over time), vomiting, diarrhea, constipation, abdominal discomfort, and reduced appetite (which contributes to therapeutic effects but can be excessive for some patients)

Published investigations report measurable biological signaling changes in controlled human or preclinical settings

Development and evaluation of innovative enteric-coated capsules for colon-specific delivery of hydrophilic biomaterials

Research has shown that the activation of matrix metalloproteinases 2 and 9 (MMP-2 and MMP-9) sets in motion events that cause inflammation, abnormalities in the extracellular matrix, tubular atrophy, and fibrosis (84, 189191)